Share on StockTwits

Omeros (NASDAQ:OMER) was the recipient of some unusual options trading on Tuesday. Stock investors acquired 223 call options on the stock, American Banking & Market News reports. This represents an increase of 132% compared to the average daily volume of 96 call options.

Omeros (NASDAQ:OMER) traded down 7.46% on Tuesday, hitting $12.90. 731,490 shares of the company’s stock traded hands. Omeros has a one year low of $4.75 and a one year high of $18.80. The stock’s 50-day moving average is $14.94 and its 200-day moving average is $12.95. The company’s market cap is $437.5 million.

Omeros (NASDAQ:OMER) last issued its quarterly earnings data on Monday, August 11th. The company reported ($0.53) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.46) by $0.07. The company had revenue of $0.45 million for the quarter, compared to the consensus estimate of $0.37 million. During the same quarter last year, the company posted ($0.48) earnings per share. Omeros’s revenue was up 221.4% compared to the same quarter last year. On average, analysts predict that Omeros will post $-2.17 earnings per share for the current fiscal year.

Omeros Corporation operates as a biopharmaceutical company focused on the discovery, development and commercialization of products focused on inflammation and disorders of the central nervous system.

Receive News & Ratings for Omeros Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omeros Co and related companies with Analyst Ratings Network's FREE daily email newsletter.